Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic immunosuppression.

Neal R Barshes1, Sarah E Goodpastor, John A Goss

  • 1Michael E. DeBakey Department of Surgery, Baylor College of Medicine, 6550 Fannin. Suite 1628, Houston, TX 77030, USA.

Frontiers in Bioscience : a Journal and Virtual Library
|February 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatopulmonary syndrome as presentation of pediatric metabolic dysfunction-associated steatohepatitis.

JPGN reports·2026
Same author

The SOFT Cluster Score as a Multifaceted Predictive Model for Postoperative Outcomes.

Transplantation direct·2026
Same author

Trends in Survival and Unmet Need Across Solid Organ Transplantation.

Journal of the American College of Surgeons·2026
Same author

A Shared Call to Action for Amputation Prevention-Beyond Benchmarks.

JAMA surgery·2026
Same author

Asynchronous transitions from high-risk hepatoblastoma to carcinoma.

Journal of hepatology·2026
Same author

Associations between socioeconomic factors and post-liver transplant mortality across recovery phases.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2025
Same journal

The CD44 protein family: roles in embryogenesis and tumor progression.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Four varieties of voltage-gated proton channels.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Lurie's tubercle-count method to test TB vaccine efficacy in rabbits.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Optical spectroscopy of breast biopsies and human breast cancer xenografts in nude mice.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

The colostrum-deprived, artificially-reared, neonatal pig as a model animal for studying rotavirus gastroenteritis.

Frontiers in bioscience : a journal and virtual library·2017
Same journal

Action of polypeptide growth factors in colon cancer; development of new therapeutic approaches.

Frontiers in bioscience : a journal and virtual library·2017
See all related articles

Effective immunosuppression is crucial for organ transplantation success. Newer drugs offer improved efficacy and fewer side effects, but research continues to seek ideal graft tolerance without generalized immunosuppression.

Area of Science:

  • Immunology
  • Pharmacology
  • Transplant Medicine

Background:

  • Clinical organ transplantation relies heavily on pharmacologic immunosuppression.
  • Early immunosuppressants like azathioprine and steroids enabled long-term graft survival but caused significant adverse effects.
  • Advancements in immunosuppressive therapies have improved outcomes in organ transplantation.

Purpose of the Study:

  • To review the evolution and mechanisms of pharmacologic immunosuppression in organ transplantation.
  • To discuss the efficacy and adverse effects of various immunosuppressive agents.
  • To highlight future directions in achieving graft tolerance.

Main Methods:

  • Review of historical and current immunosuppressive drug classes.
  • Description of mechanisms of action for antimetabolites, corticosteroids, calcineurin inhibitors, mTOR inhibitors, and monoclonal antibodies.

Related Experiment Videos

  • Discussion of clinical outcomes and adverse effects associated with these agents.

    • Main Results:

    • Azathioprine and steroids were early successful immunosuppressants with notable toxicities.
    • Calcineurin inhibitors (cyclosporine, tacrolimus) and mTOR inhibitors (rapamycin) target T-cell activation pathways.
    • Monoclonal antibodies (OKT3, daclizumab, basiliximab) offer targeted immunosuppression with improved safety profiles.

    Conclusions:

    • Significant progress has been made in immunosuppressive therapy for organ transplantation, enhancing efficacy and reducing adverse effects.
    • Current immunosuppressive medications are not perfect, with ongoing challenges in balancing efficacy and toxicity.
    • Future research aims to achieve specific graft tolerance through molecular and gene-level interventions.